Radon Exposure Tied to Higher Risk for Childhood Leukemia
By Lori Solomon HealthDay Reporter
WEDNESDAY, Oct. 16, 2024 -- Exposure to radon levels, even below current recommended levels, heightens the risk for childhood leukemia, according to a study published in the December 2024 issue of Science of the Total Environment.
Matthew Bozigar, from Oregon State University in Corvallis, and colleagues investigated the association between domestic radon exposure and childhood cancer risk in 727 U.S. counties (14 states; 41,599 people aged 0 to 19 years).
The researchers found that results from fully adjusted spatiotemporal statistical models showed a higher risk for leukemia (relative risks [RRs], 1.05; 95 percent credible interval [CrI], 1.00 to 1.09) among both sexes and males (RR, 1.06; 95 percent CrI, 1.00 to 1.12) from a 50 Bq/m3 (1.35 pCi/L) increase in radon concentration the year prior. Risk was higher for both sexes (RR, 1.08) and females (RR, 1.12) for radon exposures ≥74 Bq/m3 (2.00 pCi/L) the year prior. There were no associations for other cancer sites from prior year radon exposures.
“County-level childhood leukemia risk in both sexes was associated with average radon levels below U.S. Environmental Protection Agency guidelines recommending mitigation (148 Bq/m3 or 4.00 pCi/L),” the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Pediatric Magnet Ingestion Rates Still High
THURSDAY, May 22, 2025 -- Global pediatric magnet ingestion rates remain high and incidence has increased, despite the implementation of national policies, according to a review...
In Pediatric Leukemia, Survival Linked to Duration of Overweight, Obesity
TUESDAY, May 20, 2025 -- For children with acute lymphoblastic leukemia (ALL), longer duration of overweight or obesity is associated with lower overall and event-free survival...
Molecular Monitoring Improves Survival in Some Patients With Newly Diagnosed Leukemia
WEDNESDAY, May 14, 2025 -- Molecular monitoring of measurable residual disease (MRD), coupled with guided treatment, contributes to improved survival for patients with newly...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.